Literature DB >> 27761457

The role of galactomannan testing to diagnose invasive pulmonary aspergillosis in critically ill patients.

Maya Hites1, Eduardo Wilfrido Goicoechea Turcott2, Fabio Silvio Taccone2.   

Abstract

Entities:  

Year:  2016        PMID： 27761457      PMCID： PMC5066040          DOI： 10.21037/atm.2016.08.32

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  27 in total

1.  Clinical and autopsy diagnoses in the intensive care unit: a prospective study.

Authors:  Alain Combes; Mourad Mokhtari; Anne Couvelard; Jean-Louis Trouillet; Jérôme Baudot; Dominique Hénin; Claude Gibert; Jean Chastre
Journal:  Arch Intern Med       Date:  2004-02-23

Review 2.  Advances and challenges in management of invasive mycoses.

Authors:  Thomas F Patterson
Journal:  Lancet       Date:  2005 Sep 17-23       Impact factor: 79.321

3.  Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.

Authors:  Jutta Auberger; Cornelia Lass-Flörl; Hanno Ulmer; Elisabeth Nogler-Semenitz; Johannes Clausen; Eberhard Gunsilius; Hermann Einsele; Günther Gastl; David Nachbaur
Journal:  Int J Hematol       Date:  2008-11-05       Impact factor: 2.490

Review 4.  Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.

Authors:  Mario Cruciani; Carlo Mengoli; Juergen Loeffler; Peter Donnelly; Rosemary Barnes; Brian L Jones; Lena Klingspor; Oliver Morton; Johan Maertens
Journal:  Cochrane Database Syst Rev       Date:  2015-10-01

5.  Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease.

Authors:  Hangyong He; Lin Ding; Shuo Chang; Fang Li; Qingyuan Zhan
Journal:  Med Mycol       Date:  2010-10-11       Impact factor: 4.076

6.  A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients.

Authors:  Stijn I Blot; Fabio Silvio Taccone; Anne-Marie Van den Abeele; Pierre Bulpa; Wouter Meersseman; Nele Brusselaers; George Dimopoulos; José A Paiva; Benoit Misset; Jordi Rello; Koenraad Vandewoude; Dirk Vogelaers
Journal:  Am J Respir Crit Care Med       Date:  2012-04-19       Impact factor: 21.405

7.  A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.

Authors:  J Acosta; M Catalan; A del Palacio-Peréz-Medel; D Lora; J-C Montejo; M-S Cuetara; M-D Moragues; J Ponton; A del Palacio
Journal:  Clin Microbiol Infect       Date:  2010-11-05       Impact factor: 8.067

8.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 9.  Galactomannan detection for invasive aspergillosis in immunocompromised patients.

Authors:  Mariska M G Leeflang; Yvette J Debets-Ossenkopp; Junfeng Wang; Caroline E Visser; Rob J P M Scholten; Lotty Hooft; Henk A Bijlmer; Johannes B Reitsma; Mingming Zhang; Patrick M M Bossuyt; Christina M Vandenbroucke-Grauls
Journal:  Cochrane Database Syst Rev       Date:  2015-12-30

10.  What's new in invasive pulmonary aspergillosis in the critically ill.

Authors:  Despoina Koulenti; Dirk Vogelaers; Stijn Blot
Journal:  Intensive Care Med       Date:  2014-03-20       Impact factor: 17.440
View more
  3 in total

1.  Educational case: Coccidioidomycosis.

Authors:  Rachel Brineman; Larry Nichols
Journal:  Acad Pathol       Date:  2022-08-06

2.  Galactomannan use in clinical practice: providing free testing is not the full answer.

Authors:  Jeniffer S Dos Santos; Djuli M Hermes; Alessandro C Pasqualotto
Journal:  Braz J Infect Dis       Date:  2017-11-22       Impact factor: 3.257

3.  Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis.

Authors:  Carla M Roman-Montes; Areli Martinez-Gamboa; Paulette Diaz-Lomelí; Axel Cervantes-Sanchez; Andrea Rangel-Cordero; Jose Sifuentes-Osornio; Alfredo Ponce-de-Leon; Maria F Gonzalez-Lara
Journal:  Mycoses       Date:  2021-02-13       Impact factor: 4.931
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.